1998
DOI: 10.2337/diacare.21.11.1819
|View full text |Cite
|
Sign up to set email alerts
|

Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India.

Abstract: The data suggests that serum Lp(a) is an independent risk factor for CAD in NIDDM patients in South India.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
43
1
1

Year Published

2004
2004
2018
2018

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 69 publications
(50 citation statements)
references
References 0 publications
5
43
1
1
Order By: Relevance
“…Lp(a) has been shown to be elevated in Indian heart patients (Gambhir et al, 2000) and was an independent risk factor for CHD in NIDDM patients in South India (Mohan et al, 1998). Lp(a) is elevated in South Asians living in North America (Anand et al, 1998;Hoogeveen et al, 2001) and in Britain (Bhatnagar, 1998) in comparison with host populations.…”
Section: Introductionmentioning
confidence: 99%
“…Lp(a) has been shown to be elevated in Indian heart patients (Gambhir et al, 2000) and was an independent risk factor for CHD in NIDDM patients in South India (Mohan et al, 1998). Lp(a) is elevated in South Asians living in North America (Anand et al, 1998;Hoogeveen et al, 2001) and in Britain (Bhatnagar, 1998) in comparison with host populations.…”
Section: Introductionmentioning
confidence: 99%
“…O possível papel dos níveis plasmáticos de Lp(a) no desenvolvimento de DAC em pacientes diabéticos é controverso. Alguns estudos demonstram a associação direta entre níveis plasmáticos de Lp(a) e o desenvolvimento de DAC (4,10,13,21,22,27) , enquanto outros demonstram o contrário (9,(23)(24)(25) . Gazzaruso et al (2001) (7) demonstraram que os níveis plasmáticos de Lp(a) foram independentemente associados com DAC em pacientes com DM, entretanto os níveis dessa lipoproteína comportaram-se como fator de risco cardiovascular menos importante em pacientes diabéticos do que em indivíduos não-diabéticos.…”
Section: Discussionunclassified
“…SA patients also have increased levels of other risk factors for CAD. In particular, the increased levels of lipoprotein(a), fibrinogen, homocysteine and plasminogen activator inhibitor-1, as documented in SA patients (15)(16)(17), can potentially further increase the risk of CAD. Elevated inflammatory markers, such as C-reactive protein, may also be associated with increased prevalence of CAD in this population (18).…”
Section: Discussionmentioning
confidence: 99%